Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-03-05 @ 12:06 AM
Study NCT ID:
NCT02181660
Status:
COMPLETED
Last Update Posted:
2024-11-06
First Post:
2014-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-02
First Submit QC Date:
None
Study First Post Date:
2014-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL